Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$953M |
| 2 |
NVIDIA
NVDA
|
+$784M |
| 3 |
Meta Platforms (Facebook)
META
|
+$753M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$316M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$315M |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.17B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$506M |
| 4 |
Abbott
ABT
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$325M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Healthcare | 16.94% |
| 3 | Consumer Discretionary | 12.83% |
| 4 | Consumer Staples | 9.16% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Bolt Biotherapeutics
BOLT
$9.94M
| $619K | ﹤0.01% |
24,197
+1,360
| +6% | +$34.8K |
|
2752
Vanguard ESG US Stock ETF
ESGV
$11.4B
| $619K | ﹤0.01% |
+7,900
| New | +$619K |
|
2753
Wipro
WIT
$29B
| $617K | ﹤0.01% |
261,588
+178,188
| +214% | +$420K |
|
2754
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$653M
| $616K | ﹤0.01% |
23,700
-18,700
| -44% | -$486K |
|
2755
Cimpress
CMPR
$1.4B
| $613K | ﹤0.01% |
10,300
-9,000
| -47% | -$536K |
|
2756
ImmuCell
ICCC
$53.6M
| $612K | ﹤0.01% |
122,389
-438
| -0.4% | -$2.19K |
|
2757
Citizens
CIA
$274M
| $611K | ﹤0.01% |
253,494
-200
| -0.1% | -$482 |
|
2758
Moog Class B
MOG.B
| $611K | ﹤0.01% |
5,800
| – | – |
|
|
LTCH
2759
DELISTED
Latch, Inc. Common Stock
LTCH
| $608K | ﹤0.01% |
437,700
+50,900
| +13% | +$70.7K |
|
2760
Hennessy Advisors
HNNA
$90.3M
| $606K | ﹤0.01% |
85,825
+4,550
| +6% | +$32.1K |
|
2761
Remitly
RELY
$3.74B
| $604K | ﹤0.01% |
32,100
-144,300
| -82% | -$2.72M |
|
|
ZH
2762
Zhihu
ZH
$464M
| $604K | ﹤0.01% |
89,150
-119,067
| -57% | -$807K |
|
2763
Mistras Group
MG
$299M
| $600K | ﹤0.01% |
77,700
+31,500
| +68% | +$243K |
|
2764
Wave Life Sciences
WVE
$1.11B
| $600K | ﹤0.01% |
164,820
+133,020
| +418% | +$484K |
|
2765
Design Therapeutics
DSGN
$343M
| $599K | ﹤0.01% |
95,108
-6,643
| -7% | -$41.8K |
|
2766
iShares MSCI Thailand ETF
THD
$235M
| $599K | ﹤0.01% |
9,100
-16,900
| -65% | -$1.11M |
|
2767
VSE Corp
VSEC
$3.4B
| $596K | ﹤0.01% |
10,900
+100
| +0.9% | +$5.47K |
|
|
YRD
2768
Yiren Digital
YRD
$518M
| $595K | ﹤0.01% |
261,465
-4,300
| -2% | -$9.79K |
|
|
GOEV
2769
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $595K | ﹤0.01% |
2,697
-6,562
| -71% | -$1.45M |
|
2770
iShares Global 100 ETF
IOO
$7.17B
| $593K | ﹤0.01% |
+7,800
| New | +$593K |
|
2771
MediWound
MDWD
$194M
| $593K | ﹤0.01% |
55,644
-1,200
| -2% | -$12.8K |
|
|
ACOR
2772
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $593K | ﹤0.01% |
45,561
+1,296
| +3% | +$16.9K |
|
2773
iShares S&P 500 Growth ETF
IVW
$65.4B
| $592K | ﹤0.01% |
8,400
-27,800
| -77% | -$1.96M |
|
2774
Trustco Bank Corp NY
TRST
$746M
| $592K | ﹤0.01% |
20,676
-13,300
| -39% | -$381K |
|
2775
Electromed
ELMD
$199M
| $591K | ﹤0.01% |
55,204
+1,700
| +3% | +$18.2K |
|